Express Scripts Holding Co. engages in the provision of integrated pharmacy benefit management services. Its services include network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. It operates through the following segments: Pharmacy Benefit Management and Other Business Operations. The Pharmacy Benefit Management segment includes clinical solutions to improve health outcomes, specialized pharmacy care, home delivery pharmacy services, specialty pharmacy services, retail network pharmacy administration, benefit design consultation, drug utilization review, and drug formulary management. The Other Business Operations segment provides consulting services for pharmaceutical, biotechnology, and device manufacturers to collect scientific evidence to guide the safe, effective, and affordable use of medicines. The company was founded on July 15, 2011 and is headquartered in St. Louis, MO.
Market Price at 19-01-2018
Price to Earnings Ratio
Return on Equity (ROE)
Blog posts that reference Express Scripts Holding Co:
Once regarded as boring and fundamentally defensive, global healthcare stocks have re-emerged over the last few years as a powerhouse for future growth. Even though the S&P 500's healthcare sector is up over 20 per cent in the past year, it continues to offer more compelling entry points than its ASX-listed counterparts.
Given the strong run experienced by healthcare stocks globally, there are few – if any – absolute bargains left to pick off. Nevertheless, when you factor in their potential future upside, they still offer more compelling valuation propositions than their Aussie healthcare stocks. We found 9 future top performers in Skaffold Global.
Over the last month more than 825 companies in Skaffold Global have updated to reflect their latest interim or full year financial results. Of those 825 stocks, 344 have seen their Skaffold Scores change.
Microsoft (MSFT) and biopharmaceutical manufacturer Bristol-Myers Squibb (BMY) have joined the US A1 club, alongside Boeing Company (BA), Mastercard (MA) and Eli Lilly (LLY). In Europe Hugo Boss (BOSS) fell from A1 to A2 whilst London-listed gambling company William Hill jumped from B2 (2011 full year to A1.